Obesity: unraveling the complexity and embracing a modern approach to treatment
At the regional Pro-femina Conference, held on April 21 at the Madlenianum Opera and Theatre, Galenika brought attention to an important topic—obesity as a chronic disease that requires a new, modern approach to treatment.
Organized by Lepota i zdravlje magazine under the theme “Aware. Bold. Yourself.”, the conference brought together experts from various fields to encourage open and meaningful discussions about women’s health and quality of life.
Within this framework, the expert panel “Obesity: Unraveling the Complexity”, supported by Galenika, focused on understanding the causes of obesity and exploring modern approaches to its treatment.
Obesity is no longer a matter of personal discipline
The panel emphasized that obesity can no longer be viewed solely as a consequence of lifestyle choices or a lack of discipline. Today, it is recognized as a complex, chronic disease resulting from the interaction of hormonal, metabolic, and behavioral factors.
This understanding shifts the focus from simplified solutions toward a systematic, long-term approach to disease management, while also promoting greater understanding and reducing the stigma often experienced by people living with obesity.
An integrated approach to obesity treatment
The experts highlighted that a modern approach to obesity treatment requires an integrated strategy that includes:
- a balanced and sustainable diet
- regular physical activity
- continuous medical supervision
- an individualized treatment approach
The objective of this approach is not only weight loss but also the long-term improvement of overall health and quality of life.
The role of innovation and GLP-1 therapy
Particular attention was given to innovations in obesity treatment. The panel highlighted the important role of GLP-1 receptor agonist therapy, which helps regulate appetite and metabolic processes, enabling a more effective and sustainable approach to obesity management.
These modern therapeutic options represent a significant advancement in obesity treatment, providing patients with long-term support in managing the disease while improving clinical outcomes.
Galenika as a partner in advancing public health
The panel featured:
- Prof. Dr. Snežana Polovina, Specialist in Internal Medicine and Subspecialist in Endocrinology
- Assoc. Prof. Dr. Jelena Martinov Nestorov, Specialist in Internal Medicine and Subspecialist in Gastroenterohepatology
- Dr. Nataša Miletić Aranđelović, Senior Product Manager for the Obesity Therapeutic Area at Galenika
The discussion was moderated by Adriana Čortan.
Dr. Nataša Miletić Aranđelović, Galenika’s representative, highlighted the importance of modern therapeutic approaches, emphasizing that Galenika has ushered in a new era in the fight against obesity in the Serbian market by introducing innovative solutions as part of a broader strategy focused on the prevention and treatment of one of the major health challenges of the 21st century.
A collective response to a modern-day challenge
The panel reaffirmed that obesity, as a chronic disease, requires a coordinated response through collaboration among healthcare professionals, patients, and the pharmaceutical industry.
Through continuous education, the development of innovative therapies, and active participation in public dialogue, Galenika continues to reinforce its role as a trusted partner in advancing public health and promoting modern approaches to obesity treatment.
